Amneal Pharmaceuticals recently received U.S. FDA approvals for its generic versions of RESTASIS® (cyclosporine ophthalmic emulsion 0.05%) and PROAIR® HFA (albuterol sulfate inhalation aerosol 90 mcg) ...

Please provide your email address to receive an email when new articles are posted on . The sterile, preservative-free formulation is the generic equivalent of Restasis. In patients treated with the ...

Pure Storage Inc. (NYSE: PSTG) stock dropped in Tuesday's extended trading after the company released its third quarter earnings report. Here's a look at the details in the report. The Details: Pure ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) on Tuesday announced that the U.S. Food and Drug Administration has approved its cyclosporine ophthalmic emulsion 0.05%, a sterile formulation supplied ...

The FDA approved Amneal's cyclosporine ophthalmic emulsion 0.05%, equivalent to Restasis, for dry eye syndrome, enhancing tear production in specific patients. Amneal's ANDA for bimatoprost ophthalmic ...

Data storage solutions provider Pure Storage (NYSE:PSTG) reported Q3 CY2025 results beating Wall Street’s revenue expectations , with sales up 16% year on year to $964.5 million. Guidance for next ...

BRIDGEWATER, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (NASDAQ: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved ...

Are you the owner of a spankin' new Nintendo Switch 2 console? Have you been holding off on a memory card upgrade until prices have dropped? If you answered "yes" to both questions, then you, my ...